Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Adrianne Faber"'
Autor:
Peter J.C. Stuijt, Mette Heringa, Liset van Dijk, Adrianne Faber, Jako S. Burgers, Talitha L. Feenstra, Katja Taxis, Petra Denig
Publikováno v:
BMC Primary Care, Vol 25, Iss 1, Pp 1-14 (2024)
Abstract Background Deprescribing of medication for cardiovascular risk factors and diabetes has been incorporated in clinical guidelines but proves to be difficult to implement in primary care. Training of healthcare providers is needed to enhance d
Externí odkaz:
https://doaj.org/article/18842abeabb84167b99cdff7041a63c5
Autor:
Laura Schackmann, Mette Heringa, Majanne Wolters, Adrianne Faber, Liset van Dijk, Ellen S. Koster, Marcia Vervloet
Publikováno v:
Research in Social and Administrative Pharmacy, 19(5), 738-745. ELSEVIER SCIENCE INC
Background: Non-medical medication switches, a change to another medicine or medication label not motivated by medical reasons, occur frequently. Switches often lead to negative patient emotions, such as confusion and anger. Pharmacy staff's communic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::082900ce54d97b008d247619e9645fee
https://dspace.library.uu.nl/handle/1874/429412
https://dspace.library.uu.nl/handle/1874/429412
Publikováno v:
Drugs and Aging, 30(2), 91-102
BACKGROUND Many studies have investigated the effect of medication review on a variety of outcomes, but the elements of the interventions have been quite diverse. Moreover, implementation rates of recommendations also vary widely between studies. OBJ
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 37:674-680
Summary What is known and Objective: To determine to what extent patient interviews contribute to the identification of drug-related problems (DRPs) in home medication reviews, in terms of number, type and clinical relevance. Methods: We performed a
Autor:
Ruud B. Minderaa, Adrianne Faber, Jacqueline G. Hugtenburg, Luuk J. Kalverdijk, Lolkje T. W. de Jong-van den Berg, Hilde Tobi
Publikováno v:
European Child & Adolescent Psychiatry
European Child & Adolescent Psychiatry 19 (2010) 2
Faber, A, Kalverdijk, L J, de Jong-van den Berg, L T W, Hugtenburg, J G, Minderaa, R B & Tobi, H 2010, ' Co-morbidity and patterns of care in stimulant-treated children with ADHD in the Netherlands ', European Child and Adolescent Psychiatry, vol. 19, no. 2, pp. 159-166 . https://doi.org/10.1007/s00787-009-0075-y
European Child and Adolescent Psychiatry
European Child and Adolescent Psychiatry, Springer Verlag (Germany), 2009, 19 (2), pp.159-166. ⟨10.1007/s00787-009-0075-y⟩
European Child & Adolescent Psychiatry, 19(2), 159-166
European Child & Adolescent Psychiatry, 19(2), 159-166. SPRINGER
European Child and Adolescent Psychiatry, 19(2), 159-166. D. Steinkopff-Verlag
European Child & Adolescent Psychiatry 19 (2010) 2
Faber, A, Kalverdijk, L J, de Jong-van den Berg, L T W, Hugtenburg, J G, Minderaa, R B & Tobi, H 2010, ' Co-morbidity and patterns of care in stimulant-treated children with ADHD in the Netherlands ', European Child and Adolescent Psychiatry, vol. 19, no. 2, pp. 159-166 . https://doi.org/10.1007/s00787-009-0075-y
European Child and Adolescent Psychiatry
European Child and Adolescent Psychiatry, Springer Verlag (Germany), 2009, 19 (2), pp.159-166. ⟨10.1007/s00787-009-0075-y⟩
European Child & Adolescent Psychiatry, 19(2), 159-166
European Child & Adolescent Psychiatry, 19(2), 159-166. SPRINGER
European Child and Adolescent Psychiatry, 19(2), 159-166. D. Steinkopff-Verlag
International audience; This study aimed at investigating the use of psychosocial interventions and psychotropic co-medication among stimulant-treated children with attention-deficit hyperactivity disorder (ADHD) in relation to the presence of psychi
Publikováno v:
Pharmacy World & Science
Pharmacy World & Science, 31(5), 509-516
Pharmacy World & Science 31 (2009) 5
Pharmacy World & Science, 31(5), 509-516
Pharmacy World & Science 31 (2009) 5
Background New drugs and new formulations enter the growing market for ADHD medication. The growing awareness of possible persistence of ADHD impairment beyond childhood and adolescence resulting in increased pharmacotherapy of ADHD in adults, is als
Autor:
Maarten J. Postma, Lieven Annemans, Adrianne Faber, Luuk J. Kalverdijk, Lolkje T. W. de Jong-van den Berg, Hiltje Tobi, Michel van Agthoven
Publikováno v:
CNS Drugs, 22(2), 157-170
CNS Drugs 22 (2008) 2
CNS Drugs 22 (2008) 2
Background: Attention-deficit hyperactivity disorder (ADHD) is the most common mental health disorder in youths. Stimulants are the drugs of first choice in the treatment of ADHD. It has been suggested that full costs associated with the treatment of
Autor:
Adrianne Faber, Lolkje T. W. de Jong-van den Berg, Ron J. Keizer, Paul B. van den Berg, Hilde Tobi
Publikováno v:
European Journal of Clinical Pharmacology, 63(1), 57-63. Springer Verlag
European Journal of Clinical Pharmacology, 63(1), 57-63
European Journal of Clinical Pharmacology 63 (2007) 1
European Journal of Clinical Pharmacology, 63(1), 57-63
European Journal of Clinical Pharmacology 63 (2007) 1
Objectives An N-of-1 trial is a double-blind placebo-controlled randomized trial to objectively and systematically evaluate the individual's response. This approach seems extraordinarily suitable for assessing the efficacy of stimulants in the treatm
Autor:
Paul A. F. Jansen, Carolina J. P. W. Keijsers, Adrianne Faber, Anne J. Leendertse, Dick J. de Wildt, Jacobus Brouwers
Publikováno v:
Journal of Clinical Pharmacology, 55(8), 936. SAGE Publications Inc.
Understanding differences in the pharmacology knowledge and pharmacotherapy skills of pharmacists and physicians is vital to optimizing interprofessional collaboration and education. This study investigated these differences and the potential influen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3ff006a2160d2cd3647e5f518fd0358
https://dspace.library.uu.nl/handle/1874/332014
https://dspace.library.uu.nl/handle/1874/332014
Publikováno v:
European Journal of Clinical Pharmacology
European Journal of Clinical Pharmacology, 71(10), 1255-1262
European Journal of Clinical Pharmacology, 71(10), 1255-1262
Purpose STOPP and START criteria identify potential inappropriate prescribing and potential prescribing omissions. It is unknown whether STOPP/START criteria identify all drug-related problems. This study aims to determine to what extent STOPP/START